The aim of this study was to conduct a systematic review to compare the clinical outcomes of two different resorbable collagen membranes in terms of regenerated bone volume, postoperative complications and membrane degradation during bone regeneration procedures. Randomized controlled trials (RCT) or controlled trials (CT) that compared both techniques were reviewed on four electronic databases up to December 2015, a manual search was performed on the bibliography of the collected articles and the authors were contacted for additional references if undetected on the electronic and manual search. Membrane exposure was evaluated as a dichotomous outcome and the statistical unit was the membrane. The results were presented as relative risk (RR) with a 95% confidence interval. Eight RCTs and one CT were included in this study. The majority of the studies depicted a bone augmentation area, which ranged from 46.15% to 94.6% for the non-cross-link membranes and from 44% to 92.6% for the cross-link membranes at the 4-6 month re-entry surgery. From a total of 289 patients, a forest plot concerning the membrane exposure was constructed using the obtained RR of the included studies. The overall RR was 1.43 (95% CI: 0.85-2.39) with no statistically significant differences between the two groups, although with a marginal tendency towards higher exposure in the cross-link membrane group. This systematic review suggests the different membranes present themselves as appropriate for bone regeneration procedures, although cross-link membranes present higher rates of postoperative complications. However, more RCT with higher sample sizes are needed to evaluate the different membranes. The suggested lack of clinical differences between the compared membranes suggest that further cost-benefit ratio, tissue integration and postoperative complication oriented studies should be performed so that clinicians can take a patient-centred, evidencebased decision.
The concept of guided bone regeneration (GBR) has been used in experimental maxillofacial reconstruction since the mid-1960s. 3 According to Dahlin et al., 4 the use of a membrane technique prevents the migration of fibroblasts and soft connective tissue cells into the intended regeneration site. In the intervening period, the evolution of these bone volume growth techniques has improved. [5] [6] [7] In 1996
Hermann and Buser, 8 Based on these principles an ideal membrane used in the GBR technique plays an important role in creating space and to allow sufficient time for the newly formed bone to mature. 10 Although different non-resorbable and resorbable membranes have been developed
and their use extensively studied, there is still the need to develop a better membrane for clinical use, which should be biocompatible, cellocclusive, space creating, allow for tissue integration and be clinically manageable. 5, 11 The first grafting materials used for GBR were the non-resorbable membranes made of polytetrafluoroethylene (e-PTFE; Teflon), which had been shown to halt the migration of epithelial cells to the regenerated site where narrow bone was being produced. [12] [13] [14] The other non-resorbable membranes in use are titanium reinforced ePTFE, high-density-PTFE or titanium mesh, which are mainly used in oral and maxillofacial surgery. 15 However, these membranes require a second surgical procedure for removal and they have a higher risk of exposure to the oral environment, thus increasing the risk of secondary infection and hindering bone regeneration. [16] [17] [18] [19] [20] In the early 1990s the use of resorbable membranes [21] [22] [23] were described and developed to avoid some of the soft tissue complications of non-resorbable membranes. 24, 25 Recently, a multitude of options have been introduced to the market and resorbable membranes can now be manufactured from different materials (natural or synthetic). 6 Although the durability of the barrier effect may be diminished over the healing period 26, 27 they have several advantages such as a singlestep surgical procedure, which decreases patient morbidity and the risk to the newly regenerated tissues, 28 good tissue integration with lower risk of membrane exposure, 29, 30 radiolucency that allows imaging and their resorption eliminates the potential effects of stress shielding the regenerated bone. 20 Natural membranes can be made of collagen but have the major handicap of rapid in vivo degradation failing to provide the structural integrity necessary for bone regeneration. 31 Therefore, given the need to improve the process of degradation of resorbable collagen membranes, physical, chemical and enzymatic processes were developed to improve durability by crosslinking the existing collagen fibres and thus creating resorbable crosslinked collagen membranes. 32, 33 Owing to the reported drawbacks with membrane use, practitioners are often discouraged about performing full GBR procedures in preference to partial GBR procedures without membranes. 34, 35 Therefore, it is critical to provide the readers clear guidance when it comes to membrane choice.
The purpose of this article is to systematically review the available literature to ascertain the clinical outcomes of two different resorbable collagen membranes in terms of regenerated bone volume, postoperative complications and membrane degradation during bone regeneration procedures. Population: Healthy adult human patients in need of bone regeneration procedures to place dental implants for fixed oral rehabilitation.
| MATERIAL AND METHODS
Intervention: Bone regeneration with the use of resorbable non-crosslink collagen membrane.
Comparison: Bone regeneration with the use of cross-link collagen membrane.
Outcomes: Regenerated bone volume, degradation of membrane and the post-surgery complications such as exposure of the barrier membrane, pain, infection or oedema.
| Criteria in the selection of studies
Eligibility criteria included articles published between 2000 and 2015.
These could be meta-analyses, systematic reviews, randomized clinical trials, controlled clinical trials, pragmatic clinical trials, clinical trials and clinical studies. 
| Data source and electronic search strategies

| Additional strategies and other resources
To obtain additional results a manual search was conducted at In addition, all the references of the included articles were assessed to determine if any other manuscript regarding the subject was present. If so, the title and abstract were analysed to ascertain if they met the inclusion criteria. The corresponding authors of the included studies were contacted via email and, when contact was possible, the authors were questioned concerning the existence of additional works of the same genre.
| Data collection and quality assessment
To assess the risk of bias and the quality of the included articles a questionnaire from the Critical Appraisal Skills Program (CASP) of the Public Health Resource Unit (2006) 39 was used.
Two operators who did not have access to their counterpart evaluations performed independent assessments. An inter-rater reliability test was performed with a kappa of 0.88, which was above the 0.8 to be considered as good agreement. 40 On completion the evaluations that differed between them were discussed until a consensus was reached.
Studies with more than half of the questions in the CASP questionnaire rated as negative were considered to have a high risk of bias.
Therefore, only the trials whose CASP evaluations were ≥50% were selected for the final analysis in this review.
The studies used for this review were those that, after being detected in the electronic databases or by means of manual search or being supplied by the authors of previous studies, could surpass the three phases of evaluation.
| Data analysis
All data collection was done using an Excel document designed to express all the data regarding the variables included in this study as a 
| RESULTS
| Literature research and included studies
The selection process on the studies included is shown in Figure 1 .
The search resulted in 520 articles after removing the duplicates in the various databases. Of these, after the analysis of their abstracts, nine
were identified for possible inclusion in this review. In addition, one more article was found to be eligible in the manual search. Although only two of the authors, who were contacted, responded; no additional data were added to this review. The remaining articles were subjected to the CASP quality assessment 39 (Table 1 ) of which one article 45 was excluded for presenting a CASP evaluation with a high risk of bias. Thus, a total of nine articles remained.
| Population and intervention
All included studies were clinical trials comparing two distinctly processed resorbable membranes used for bone regeneration, of which eight were randomized studies and one was a controlled clinical trial. 29 A total of 363 patients were studied and the mean follow-up ranged from 4 months to 6 years. An Excel 
| Description of the studies
| Surgical variables
All the authors specified the brand of the dental implants used when bone regeneration was required except for Tal et al. 46 From 
| Outcomes: volumetric bone measurements
The amount of bone volume regeneration was measured by the use of a millimetre periodontal probe with previously established methods, namely, the measurement of height as the distance from the most apical aspect of the buccal crestal bone to the implant platform margin and the width as the widest mesio-distal dimension of the buccal defect. Depending on the manuscripts the results were presented as a mean percentage, median gain in millimetres of bone augmentation or frequency distribution of residual defect height at 4 months.
The majority of the studies detected from poor to acceptable bone augmentation area, which ranged from 46.15% to 94.6% for the noncross-link membranes and from 44% to 92.6% for the cross-link membranes at 4-6 months re-entry surgery.
The two publications from Schwarz et al. 48, 49 aimed to assess the peri-implant health 4 years after bone augmentation. The residual defect on a follow-up of 4 months from the GBR surgery was also recorded and categorized in to three groups. This was done according to the defect size found at re-entry from bone augmentation as: 0 mm for absence of residual defect or control group; ≤1 mm for minimal residual defect or test group 1; and ≥1 mm for the advanced residual defect or test group 2, and the results are expressed in Table 1 .
The Friedmann et al. 52 article in addition to determining bone volume augmentation in vivo by previously described methods, included F I G U R E 1 PRISMA flowchart diagram of the search strategy. Articles are sorted by identification, screening and eligibility ex vivo measurements. This was undertaken before and after the reflection of a muco-periosteal flap at the bone regeneration surgery to document hard and soft tissue dimensions and at the re-entry 6 months later to make comparisons. The morphometric outcomes given by the authors compare the median width and height results taken from the casts between both surgeries by taking two reference points and were expressed in millimetres. The results are reported in Table 1 .
| Membrane durability
The barrier durability and integrity on regenerated bone dehiscence's was carried out by Tal et al. 46 and Lee et al. 53 from histologic sections via biopsies to assess the membrane degradation with 6 and 4 month follow-ups respectively. The findings from the biopsy samples ranged from 77.8% to 100% on membrane remnants from the histologic observations on the cross-link group while no remnant was observed in the non-cross-link membrane group, although no statistical analysis was performed for this outcome.
| Post-surgery complications
Post-surgical complications may appear during a GBR, premature membrane exposure being the most frequent, described in seven of the nine studies included in this systematic review.
Spontaneous non-cross-linked membrane exposures ranged from 11% to 32.1% (individual results depicted in Table 1 ). From the crosslinked membrane groups, Ossix ® cross-linked membranes recorded rates from 12.5% to 50% and for VN ® cross-linked membranes, rates ranged from 52.17% to 56%. All authors from the included studies reported statistically significant differences between the two types of membranes for this outcome.
A forest plot concerning the membrane exposure was constructed using the obtained relative risk of the included studies. The obtained heterogeneity was Q=9.34 (df=6) and the I 2 =35.78%, corresponding to a moderate heterogeneity value. The overall relative risk was 1.43, with 95% confidence intervals, as expressed in Figure 2 . According to the analysed data, no statistically significant differences were obtained between the two groups although with a marginal tendency to higher exposure in the cross-link membrane group.
With regard to other post-surgery complications, inflammation and swelling have been assessed by Becker et al. 47 corresponding to 30.4% and 13% respectively, as well as Annen et al. 51 reporting infection/membrane removal in 33.3% for the cross-link membranes group, while no other complication was described for the non-cross-linked membrane groups in both studies.
| DISCUSSION
The objective of this study was to investigate through the current literature the different biological behaviours between two types of resorbable membranes on bone augmentation procedures for implant placement. The use of membranes allows for the hindrance of the migration of connective tissue maintaining a space where the bone is in formation. 9 All membranes employed have advantages and disadvantages that should be analysed to optimize our clinical procedures. 7 All the clinical studies that were included in this review directly compared two types of resorbable membranes for GBR carried out in humans and always under conditions as close as possible to those observed in daily clinical practice. Of the 10 studies included for this systematic review, nine were randomized controlled trials (RCTs) and one was controlled clinical trial, achieving a high evidence-based level with a low risk of bias as determined by the CASP quality assessment 39 performed.
From the outcomes considered in this systematic review and assessed by the different authors, the regenerated bone volume was the main variable in determining when to perform a GBR technique.
Except for Tal At this point the differences between membranes show a tendency to a higher exposure rate in the cross-linked membranes although due to small sample sizes no statistical significance was obtained. These results should be discussed in the context where GBR takes 4-6 months to complete, and as demonstrated by von Arx et al. 55 and Tal et al., 46 the cross-link membranes have longer degradation times compared with the non-cross-link membranes so they have greater probability to become exposed to the oral environment over similar follow-up periods. This biological behaviour could also be the reason why cross-link membranes present higher prevalence of other post-surgery complications such as inflammation, swelling or infection.
In fact, there is no clear evidence in the literature regarding the process by which there is a higher prevalence of exposure in the cross-link membranes vs non-cross-link membranes and if there is any correlation with the resorption degree of the membranes. 46 Some possible mechanisms for explaining the higher rate of exposure with 30 who reported a 96.4% defect fill over the non-cross-linked membrane groups. Some animal studies, which compared both resorbable membranes, described no statistical differences in defect fill as did Bornstein et al. 58 and Kelley and Kelley. 41 When assessing postoperative complications, Friedmann et al. 59 did not compare different membranes and only analysed the exposure rate in cross-linked resorbable membranes, which equated to 62%, while Chiapasco and Zaniboni 25 in their systematic review described a mean exposure rate of 5%. The pattern in biodegradation and durability from animal specimens of different types of resorbable membranes and assessed by histological findings from Rothamel et al. 57 and von Arx et al. 55 are in agreement with Tal et al. 46 in their human clinical trial where cross-linked collagen showed more durability during the GBR compared to the non-cross-linked collagen membrane.
| CONCLUSION
Within the limitations of the present systematic review, it can be con- 
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F I G U R E 2 Analysis and forest plot for the results of the included studies that determined membrane exposure. Ev/Trt represents the test (cross-linked membranes) group, while Ev/Ctrl represents the control (non-cross-linked membranes) group. Red line represents the average for all results, and the vertical black line represents the no-effect line
